GlassScriptPhysician profile
James A Lucio
NPI 1649235151
$7,096.07
in general payments reported to CMS, 2019-2025
37 companies · $88.07 in 2025
The $88.07 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,543 · 2020: $1,062 · 2021: $1,649 · 2022: $1,819 · 2023: $904 · 2024: $30.67 · 2025: $88.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.75 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,473.82 | 2019-2023 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $964.58 | 2019-2023 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $614.60 | 2019-2023 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Actelion Pharmaceuticals US, INC. | $497.98 | 2019-2023 | |
| Genzyme Corporation | $303.06 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $286.04 | 2019-2023 | Dupixent |
| Grifols USA, LLC | $277.94 | 2019-2023 | Prolastin-C Liquid |
| Genentech USA, INC. | $234.99 | 2019-2020 | |
| Mylan Specialty L.P. | $212.71 | 2019-2023 | Yupelri |
| Jazz Pharmaceuticals INC. | $185.98 | 2020-2023 | |
| Paratek Pharmaceuticals, INC. | $182.17 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $181.69 | 2021-2022 | |
| Insmed, INC. | $179.98 | 2019-2024 | Arikayce |
| Harmony Biosciences LLC | $168.69 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $140.65 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $123.26 | 2022 | |
| Novartis Pharmaceuticals Corporation | $119.13 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $115.80 | 2021-2023 | Glassia, Cuvitru |
| Phadia US INC. | $106.60 | 2019 | |
| Abiomed | $102.50 | 2024-2025 | Impella |
| Mallinckrodt Hospital Products INC. | $94.34 | 2022 | |
| Merck Sharp & Dohme LLC | $84.68 | 2022-2023 | Belsomra |
| Electromed, INC. | $62.41 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $48.36 | 2019-2020 | |
| Abbvie INC. | $42.59 | 2021 | |
| Axsome Therapeutics, INC. | $42.17 | 2023 | Sunosi |
| Allergan, INC. | $37.70 | 2019 | |
| Ethicon INC. | $36.04 | 2019 | |
| Covis Pharma Gmbh | $33.72 | 2021 | |
| Eisai INC. | $25.00 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $19.56 | 2019 | |
| Advanced Respiratory, INC | $19.03 | 2020 | |
| Amgen INC. | $18.60 | 2022 | |
| Inogen, INC. | $18.43 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Zoll Respicardia, INC. | $15.49 | 2023 | Remede System |
| Circassia INC. | $13.26 | 2020 | |
| Philips North America LLC | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lucio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.